1991 - Mechanism of biochemical modulation in chemotherapy for gastro intestinal tract cancer
1988 - 敗血症時の凝固,線溶機能の変動
1988 - Changes in coagulation and fibrinolysis in sepsis
1986 - 敗血症における臓器不全の発生機序
1986 - mechanism of organ failure in sepsis
新規DIC治療薬の評価
新規敗血症治療の評価
evaluation of newly developped drug for DIC
evaluation of newly developped treatment for sepsis
全件表示
論文 (35件):
Iba T, Levy JH, Aihara K, Kadota K, Tanaka H, Sato K, Nagaoka I. Newly developed recombinant antithrombin protects the endothelial glycocalyx in an endotoxin-induced rat model of sepsis. Int J Mol Sci. 2020. 22. 176
Iba Toshiaki, Levy Jerrold H, Hirota Tatsuhiko, Hiki Makoto, Sato Koichi, Murakami Taisuke, Nagaoka Isao. Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis. THROMBOSIS RESEARCH. 2018. 171. 1-6
Toshiaki Iba, Tatsuhiko Hirota, Koichi Sato, Isao Nagaoka. Protective effect of a newly developed fucose-deficient recombinant antithrombin against histone-induced endothelial damage. International Journal of Hematology. 2018. 107. 5. 528-534
Kazuhiro Takehara, Taisuke Murakami, Kyoko Kuwahara-Arai, Toshiaki Iba, Isao Nagaoka, Kazuhiro Sakamoto. Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model. EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2017. 13. 6. 2969-2974